Abstract

Investigating the gut microbiome and metabolome frequently requires faecal samples, which can be difficult to obtain. Previous studies have shown that rectal swabs are comparable to faecal samples for analysing gut microbiota composition and key metabolites. In this study, 3D printed rectal swabs were compared with conventional flocked swabs and faecal samples, due to the potential advantages 3D printing as a technique offers for swab production and development. 16S rRNA gene sequencing, qPCR and metabolite profiling (using 1H-NMR spectroscopy) were performed on swab and faecal samples from healthy participants. Faecal calprotectin and total protein analysis were performed on samples from inflammatory bowel disease (IBD) patients. There were no significant differences between both swab types and faecal samples when assessing key measures of alpha and beta diversity, and differences in the abundance of major phyla. There was a strong correlation between both swab types and faecal samples for all combined metabolites detected by NMR. In IBD patients, there was no significant difference in faecal calprotectin and total protein levels between both swab types and faecal samples. These data lead us to conclude that 3D printed swabs are equivalent to flocked swabs for the analysis of the gut microbiome, metabolome and inflammation.

Details

Title
3D printed rectal swabs for assessing the gut microbiome, metabolome and inflammation
Author
Perry, Robert W. 1   VIAFID ORCID Logo  ; Mullish, Benjamin H. 1   VIAFID ORCID Logo  ; Alexander, James L. 2   VIAFID ORCID Logo  ; Shah, Raashi 3 ; Danckert, Nathan P. 4   VIAFID ORCID Logo  ; Blanco, Jesus Miguens 5   VIAFID ORCID Logo  ; Roberts, Lauren 3   VIAFID ORCID Logo  ; Liu, Zhigang 3   VIAFID ORCID Logo  ; Chrysostomou, Despoina 3   VIAFID ORCID Logo  ; Radhakrishnan, Shiva T. 6   VIAFID ORCID Logo  ; Balarajah, Sharmili 1   VIAFID ORCID Logo  ; Barry, Rachael 3   VIAFID ORCID Logo  ; Hicks, Lucy C. 1   VIAFID ORCID Logo  ; Williams, Horace R. T. 1   VIAFID ORCID Logo  ; Marchesi, Julian R. 3   VIAFID ORCID Logo 

 Imperial College London, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111); Imperial College Healthcare NHS Trust, Departments of Gastroenterology and Hepatology, St Mary’s Hospital, London, UK (GRID:grid.417895.6) (ISNI:0000 0001 0693 2181) 
 Imperial College London, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111); Imperial College Healthcare NHS Trust, Departments of Gastroenterology and Hepatology, St Mary’s Hospital, London, UK (GRID:grid.417895.6) (ISNI:0000 0001 0693 2181); St Marks Hospital, Department of Gastroenterology, London, UK (GRID:grid.416510.7) 
 Imperial College London, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111) 
 King’s College London, Department of Twin Research and Genetic Epidemiology, School of Life Course & Population Sciences, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764) 
 Stanford University, Department of Bioengineering, Stanford, USA (GRID:grid.168010.e) (ISNI:0000 0004 1936 8956) 
 Imperial College London, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111); St Marks Hospital, Department of Gastroenterology, London, UK (GRID:grid.416510.7) 
Pages
16613
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3082445460
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.